TD Bank Group Expects "Zero Catastrophe Claims" For Q1-March 2024-www.financetom.com

TD Bank Group Expects "Zero Catastrophe Claims" For Q1

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

TD Bank Group Expects "Zero Catastrophe Claims" For Q1

Feb 7, 2025 6:36 AM

09:10 AM EST, 02/07/2025 (MT Newswires) -- TD Bank Group (TD.TO) on Friday said it expects zero catastrophe claims after reinsurance and before tax to be reflected in the Bank's Wealth Management & Insurance segment's first-quarter results.

The bank's shares were last seen up US$0.07 to near US$58, in U.S. pre-market trading.

Previous page： AbbVie to buy Landos to expand pipeline of immunity-related illnesses Next page： Novo ready to seek German insurance coverage of Wegovy for heart use

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

AbbVie to buy Landos to expand pipeline of immunity-related illnesses

Mar 25, 2024

March 25 (Reuters) - AbbVie ( ABBV ) said on Monday it would acquire drug developer Landos Biopharma ( LABP ) for up to $212 million as the Humira-maker aims to expand its pipeline of medicines to treat immune system-related illnesses. ...

Novo ready to seek German insurance coverage of Wegovy for heart use

Mar 25, 2024

FRANKFURT, March 25 (Reuters) - Novo Nordisk said it plans to seek coverage by Germany's public health insurance scheme for the use of its Wegovy drug to cut the risk of strokes and heart attacks, if the drug's extended indication wins European approval. ...

Olink Swings to Q4 Net Loss, Revenue Rises

Mar 25, 2024

08:42 AM EDT, 03/25/2024 (MT Newswires) -- Olink Holding ( OLK ) reported a Q4 net loss Monday of $0.06 per diluted share, swinging from net income of $0.05 a year earlier. Three analysts polled by Capital IQ expected earnings of $0.16. Revenue for the quarter ended Dec. 31 was $68.6 million, up from $57.9 million a year earlier. Four...

--AbbVie to Acquire Landos Biopharma for About $137.5 Million

Mar 25, 2024

08:41 AM EDT, 03/25/2024 (MT Newswires) -- Price: 178.68, Change: +0.23, Percent Change: +0.13 ...